Pay in 4 interest-free payments of $43.75 Learn more
Ships within 48 hours · Estimated delivery Sep 21 - Sep 26
patent Anti-Nav1
suggesting this pathway may be a useful therapeutic target in inflammatory diseases such as asthma
They are designated at type I (slow twitch) and type II (fast twitch)
the receptor dissociates from accessory proteins
Anti-human VEGFR1 / FLT1 (Abbott patent Anti-Flt1 Biosimilar) Size:1 mg patent Anti-Nav1Application ELISA, Bioactivity: FACS, Functional assay, Research in vivo Reactivity Human Target Target Name VEGFR1 FLT1 Target Uniprot P17948 Overview Catalog# BIO0411SM Product Name Anti human VEGFR1 FLT1 (Abbott patent Anti Flt1 Biosimilar) Specifications Conjugation None Clone# Abbott patent Anti Flt1 Formulation 100 mM Pro Ac 20mM Arg pH 5. 0 Storage For long term storage, the produce should be stored at 20 or lower. Reconstitution Dissolve with
US$ 19.00
US$ 21.00
US$ 62.99
US$ 25.95
US$ 112.00
US$ 15.95
US$ 39.00
US$ 29.00
US$ 18.95
Click on item details to customize. custom-print-1851" loading="lazy"/>
